0,791  0,005  GST A substrate
0,680  0,004  Ulceration
0,651  0,010  5 Hydroxytryptamine release stimulant
0,582  0,015  CTGF expression inhibitor
0,567  0,005  Anesthetic general
0,576  0,017  Antiallergic
0,558  0,003  GST M1-1 substrate
0,571  0,022  Cholesterol antagonist
0,586  0,038  Caspase 9 stimulant
0,555  0,011  FMO1 substrate
0,547  0,014  Calcium channel L-type activator
0,516  0,004  Interleukin 4 antagonist
0,532  0,023  5 Hydroxytryptamine release inhibitor
0,536  0,030  CYP2C9 substrate
0,515  0,012  Platelet antagonist
0,489  0,016  Antipyretic
0,463  0,006  5 Hydroxytryptamine uptake stimulant
0,486  0,037  Antipruritic, allergic
0,443  0,006  GST P1-1 substrate
0,469  0,037  Aldehyde oxidase inhibitor
0,449  0,020  UGT2B4 substrate
0,449  0,024  NOS2 expression inhibitor
0,508  0,084  Antiinflammatory
0,436  0,014  Calcium channel activator
0,454  0,037  Antithrombotic
0,456  0,039  GABA C receptor rho-3 antagonist
0,420  0,004  Carcinogenic, group 1
0,442  0,030  Lipoprotein disorders treatment
0,417  0,006  Tyrosine 3 hydroxylase inhibitor
0,431  0,026  Cardiovascular analeptic
0,424  0,021  Antidiabetic symptomatic
0,465  0,066  Antiarthritic
0,412  0,015  FMO3 substrate
0,434  0,037  Antihypercholesterolemic
0,407  0,013  Non-steroidal antiinflammatory agent
0,440  0,055  Histamine release inhibitor
0,388  0,004  Excitatory amino acid transporter EAAC1 inhibitor
0,399  0,017  Flavin-containing monooxygenase substrate
0,395  0,019  Platelet aggregation inhibitor
0,408  0,033  UGT1A9 substrate
0,425  0,058  Transcription factor NF kappa B inhibitor
0,378  0,011  Pneumotoxic
0,400  0,041  CYP2C19 substrate
0,364  0,011  Alpha-N-acetylglucosaminidase inhibitor
0,380  0,029  Hypolipemic
0,403  0,054  Vasodilator, peripheral
0,352  0,005  Histidine decarboxylase inhibitor
0,391  0,045  Teratogen
0,343  0,004  Photosensitizer
0,394  0,063  Toll-Like receptor agonist
0,394  0,063  Toll-Like receptor 7 agonist
0,367  0,036  Interleukin antagonist
0,346  0,015  Antieczematic atopic
0,356  0,027  Antihypertriglyceridemic
0,353  0,025  Abortion inducer
0,367  0,039  Sensitization
0,373  0,045  Vasodilator, coronary
0,347  0,020  Platelet adhesion inhibitor
0,354  0,033  Insulysin inhibitor
0,357  0,036  Sodium/bile acid cotransporter inhibitor
0,366  0,047  Embryotoxic
0,396  0,076  15-Lipoxygenase inhibitor
0,334  0,015  Gastrin inhibitor
0,331  0,014  Allergic rhinitis treatment
0,402  0,090  Cyclophilin D inhibitor
0,402  0,090  Antidiabetic
0,335  0,025  Eye irritation, high
0,348  0,038  Hypoglycemic
0,378  0,070  Antiasthmatic
0,345  0,038  Superoxide dismutase inhibitor
0,311  0,005  Antieczematic
0,400  0,100  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,333  0,033  Antiulcerative
0,308  0,009  Cystathionine beta-synthase inhibitor
0,305  0,009  GABA C receptor agonist
0,309  0,014  Insulin sensitizer
0,341  0,054  Analeptic
0,340  0,054  Radioprotector
0,289  0,004  Interleukin 5 antagonist
0,305  0,020  Anesthetic
0,338  0,054  Lipoxygenase inhibitor
0,371  0,089  TNF expression inhibitor
0,316  0,034  Peroxidase inhibitor
0,320  0,039  Interleukin agonist
0,318  0,040  UGT1A6 substrate
0,290  0,019  Cyclooxygenase inhibitor
0,276  0,005  Prostaglandin antagonist
0,345  0,075  Thyroid hormone antagonist
0,326  0,057  Interleukin 2 agonist
0,356  0,087  CYP2C19 inhibitor
0,288  0,022  Interferon gamma antagonist
0,276  0,010  Ferrochelatase inhibitor
0,335  0,069  ICAM1 expression inhibitor
0,282  0,018  Interleukin 6 antagonist
0,271  0,007  Cyclooxygenase 3 inhibitor
0,290  0,029  Antimutagenic
0,314  0,053  Antihypoxic
0,296  0,037  Antiparkinsonian, rigidity relieving
0,261  0,003  DOPA decarboxylase inhibitor
0,266  0,009  GABA C receptor rho-2 antagonist
0,280  0,025  Skin irritative effect
0,279  0,025  Acaricide
0,264  0,010  Phobic disorders treatment
0,269  0,017  Succinate dehydrogenase inhibitor
0,322  0,071  Apoptosis antagonist
0,333  0,085  CYP3A4 substrate
0,269  0,022  Nitric-oxide synthase stimulant
0,272  0,027  CYP2B6 inhibitor
0,278  0,033  VCAM1 expression inhibitor
0,259  0,019  Cyclooxygenase 1 inhibitor
0,277  0,039  Sedative
0,294  0,056  Transcription factor STAT3 inhibitor
0,250  0,013  UGT2B10 substrate
0,263  0,028  UGT1A3 substrate
0,288  0,053  Antiglaucomic
0,303  0,069  Spasmolytic
0,282  0,049  Cyclic AMP phosphodiesterase inhibitor
0,311  0,082  Thyroid hormone beta antagonist
0,237  0,009  Arachidonic acid antagonist
0,289  0,061  Chemoprotective
0,258  0,032  Antipruritic, non-allergic
0,240  0,016  ATPase inhibitor
0,302  0,081  CYP2D6 substrate
0,270  0,048  Calpain inhibitor
0,262  0,042  DNA methylase inhibitor
0,248  0,029  Amylase inhibitor
0,295  0,078  Respiratory analeptic
0,259  0,043  DNA methyltransferase I inhibitor
0,265  0,049  Chemopreventive
0,234  0,019  SULT1A3 substrate
0,227  0,012  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,273  0,058  Vasodilator
0,219  0,004  GST T1-1 substrate
0,237  0,024  NADPH oxidase inhibitor
0,287  0,074  CYP1A2 substrate
0,224  0,011  Catalase inhibitor
0,252  0,041  UGT2B7 substrate
0,215  0,004  Acetylcholine release stimulant
0,271  0,061  Cardiodepressant
0,214  0,004  Prostaglandin D2 antagonist
0,277  0,067  DNA damaging
0,237  0,027  Phospholipase A2 inhibitor
0,313  0,106  Calpain 2 inhibitor
0,221  0,014  Cathepsin G inhibitor
0,240  0,034  Tumour necrosis factor antagonist
0,229  0,024  Cyclooxygenase 2 inhibitor
0,228  0,023  Uterine stimulant
0,273  0,070  Aryl hydrocarbon receptor agonist
0,289  0,086  12-Lipoxygenase inhibitor
0,252  0,048  RNA-directed DNA polymerase inhibitor
0,274  0,071  Transcription factor STAT inhibitor
0,225  0,023  Antianemic
0,232  0,031  Carcinogenic, group 3
0,284  0,083  NOS3 expression inhibitor
0,290  0,089  Antineoplastic (endocrine cancer)
0,242  0,043  Neurotrophic factor enhancer
0,312  0,114  Atherosclerosis treatment
0,204  0,007  Vanilloid agonist
0,264  0,067  Proliferative diseases treatment
0,223  0,026  Neurotensin receptor agonist
0,288  0,093  Antihypertensive
0,252  0,058  Psychostimulant
0,208  0,014  UGT2B1 substrate
0,203  0,009  Carcinogenic, group 2A
0,208  0,014  Adenylate kinase inhibitor
0,216  0,023  Antirickettsial
0,204  0,011  Vanilloid 1 agonist
0,240  0,047  Antiviral (West Nile virus)
0,217  0,026  Cocaine dependence treatment
0,304  0,113  CYP2C9 inhibitor
0,264  0,074  Radiosensitizer
0,200  0,010  Actinic keratosis treatment
0,221  0,031  Aldehyde oxidase substrate
0,209  0,020  Toll-Like receptor 2 antagonist
0,202  0,013  Mucolytic
0,302  0,113  Immunosuppressant
0,222  0,034  Protein kinase stimulant
0,217  0,029  Monophenol monooxygenase inhibitor
0,255  0,069  5 Hydroxytryptamine 1E antagonist
0,196  0,011  TRPA1 agonist
0,225  0,041  Age-related macular degeneration treatment
0,200  0,018  SULT1A1 substrate
0,196  0,014  Interleukin 8 antagonist
0,217  0,035  VEGF expression inhibitor
0,206  0,026  Antihyperlipoproteinemic
0,190  0,010  GABA C receptor rho-1 antagonist
0,275  0,095  CYP3A4 inhibitor
0,187  0,007  Interferon agonist
0,241  0,062  Antihypotensive
0,266  0,087  Hypoxia-inducible factor 1 alpha inhibitor
0,204  0,026  Cholesterol synthesis inhibitor
0,187  0,008  Toll-Like receptor 4 antagonist
0,210  0,032  Genotoxic
0,254  0,077  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,207  0,030  Interleukin 1 antagonist
0,214  0,038  UGT2B15 substrate
0,178  0,004  Granulocyte macrophage colony stimulating factor agonist
0,232  0,058  Septic shock treatment
0,208  0,035  UGT2B9 substrate
0,193  0,021  Interleukin 1b antagonist
0,209  0,039  Phospholipase C inhibitor
0,177  0,007  Antifungal (Pneumocystis)
0,187  0,018  Carbonic anhydrase III inhibitor
0,200  0,032  Catenin beta inhibitor
0,214  0,046  Antianorexic
0,245  0,077  Tumour necrosis factor alpha release inhibitor
0,182  0,014  Sphingosine 1-phosphate receptor 4 antagonist
0,202  0,034  Hexokinase inhibitor
0,179  0,012  ABCA1 expression enhancer
0,223  0,056  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,175  0,009  Peroxisome proliferator-activated receptor gamma agonist
0,186  0,020  Coagulant
0,206  0,041  Antiparkinsonian, tremor relieving
0,239  0,074  Free radical scavenger
0,188  0,023  Expectorant
0,223  0,058  UGT1A1 substrate
0,233  0,069  Antiparasitic
0,257  0,093  Immunostimulant
0,181  0,017  GABA C receptor antagonist
0,173  0,010  Ca2+-transporting ATPase inhibitor
0,164  0,004  Estrogen-related receptor beta agonist
0,237  0,076  DNA synthesis inhibitor
0,171  0,011  Macrophage migration inhibitory factor inhibitor
0,209  0,049  5 Hydroxytryptamine 3E antagonist
0,263  0,105  Immunomodulator
0,182  0,024  Adenylate cyclase stimulant
0,181  0,024  Shock treatment
0,162  0,006  GABA aminotransferase inhibitor
0,231  0,076  Cytostatic
0,173  0,018  HIV-1 integrase (Overall Integration) inhibitor
0,202  0,047  Cytidine deaminase inhibitor
0,164  0,011  Glutamate decarboxylase inhibitor
0,170  0,018  Calcium antagonist
0,170  0,018  Heat shock protein 70 antagonist
0,240  0,089  Antioxidant
0,162  0,011  Antidote, mercury
0,159  0,010  Glutathione S-transferase inhibitor
0,165  0,016  Triose-phosphate isomerase inhibitor
0,219  0,070  Anticonvulsant
0,156  0,009  Alcohol oxidase inhibitor
0,273  0,126  Stroke treatment
0,160  0,014  Interleukin 1 beta converting enzyme inhibitor
0,190  0,046  Melanin inhibitor
0,168  0,025  Antiprotozoal (Babesia)
0,144  0,002  Sodium-dependent vitamin C transporter 2 inhibitor
0,182  0,040  Raynaud's phenomenon treatment
0,190  0,050  Toxic, respiratory center
0,177  0,039  Anesthetic local
0,145  0,007  Elastase 1 inhibitor
0,168  0,030  Aminopeptidase B inhibitor
0,162  0,025  UDP-glucose 4-epimerase inhibitor
0,173  0,036  Aldehyde dehydrogenase inhibitor
0,157  0,020  Carbonic anhydrase XIII inhibitor
0,170  0,034  Sphingosine 1-phosphate receptor 5 antagonist
0,165  0,030  Falcipain 3 inhibitor
0,155  0,020  Carbonic anhydrase VI inhibitor
0,139  0,005  Interferon inducer
0,200  0,067  Antihelmintic
0,163  0,032  Microtubule formation inhibitor
0,142  0,012  Glutamate release inhibitor
0,184  0,054  Protein-tyrosine phosphatase inhibitor
0,166  0,036  Cathepsin H inhibitor
0,145  0,016  Carbonic anhydrase V inhibitor
0,149  0,020  Electrolyte absorption antagonist
0,149  0,021  Porphobilinogen synthase inhibitor
0,190  0,062  UGT1A4 substrate
0,186  0,058  Antihelmintic (Nematodes)
0,157  0,029  Bronchodilator
0,158  0,031  Gastritis treatment
0,131  0,005  Aconitate hydratase inhibitor
0,152  0,026  Gastric antisecretory
0,194  0,069  Nitric oxide antagonist
0,163  0,039  Proteasome inhibitor
0,169  0,046  Antifungal enhancer
0,154  0,031  Choleretic
0,132  0,010  Glycine receptor agonist
0,131  0,009  Narcotic antagonist
0,133  0,011  Hyperparathyroidism treatment
0,134  0,012  Leukotriene synthesis inhibitor
0,175  0,055  Hair growth stimulant
0,170  0,049  Mannose-6-phosphate isomerase inhibitor
0,134  0,014  Carbonic anhydrase VA inhibitor
0,198  0,079  Cytotoxic
0,156  0,037  Rhinitis treatment
0,190  0,071  P-glycoprotein inhibitor
0,154  0,036  Sphingosine 1-phosphate receptor 2 antagonist
0,159  0,040  Antihelmintic (Trematoda)
0,148  0,030  Antihelmintic (Fasciola)
0,167  0,050  Cytokine production inhibitor
0,215  0,098  Vascular (periferal) disease treatment
0,191  0,074  Carcinogenic
0,131  0,015  Phenylalanine 4-hydroxylase inhibitor
0,137  0,021  Phosphofructokinase-1 inhibitor
0,137  0,021  UGT2B11 substrate
0,147  0,032  Carbonic anhydrase XV inhibitor
0,134  0,019  Lanosterol 14 alpha demethylase inhibitor
0,211  0,097  Antineoplastic (liver cancer)
0,241  0,127  Antineoplastic (osteosarcoma)
0,118  0,005  Fumarate hydratase inhibitor
0,152  0,038  Carcinogenic, group 2B
0,183  0,070  LDLR expression enhancer
0,117  0,006  Antidote, organophosphates
0,154  0,043  Antibacterial (Helicobacter pylori)
0,149  0,038  5-Lipoxygenase inhibitor
0,151  0,040  Glutathione S-transferase substrate
0,164  0,054  Antiprotozoal (Coccidial)
0,122  0,013  NMDA receptor agonist
0,166  0,057  Thiol protease inhibitor
0,130  0,022  Glutamate (mGluR7) agonist
0,179  0,071  Macular degeneration treatment
0,141  0,033  Mediator release inhibitor
0,163  0,055  CF transmembrane conductance regulator agonist
0,208  0,101  Acute neurologic disorders treatment
0,176  0,069  3C-like protease (Human coronavirus) inhibitor
0,166  0,060  Insulin secretagoues
0,129  0,024  NADH dehydrogenase inhibitor
0,179  0,075  Diabetic retinopathy treatment
0,134  0,030  Prolactin inhibitor
0,138  0,034  Sulfotransferase substrate
0,109  0,005  SULT2A1 substrate
0,118  0,014  Biliverdin reductase inhibitor
0,120  0,017  Sphingosine 1-phosphate receptor 4 agonist
0,143  0,040  Antiviral (Papilloma)
0,140  0,037  Antiviral (Influenza B)
0,110  0,006  Glutamate (mGluR7) antagonist
0,139  0,037  Caspase 3 inhibitor
0,168  0,066  Restenosis treatment
0,120  0,019  Aminopeptidase I inhibitor
0,129  0,028  Antispirochetal
0,116  0,016  Caspase 7 inhibitor
0,147  0,048  Cell adhesion inhibitor
0,142  0,043  Menstruation disorders treatment
0,106  0,007  Potassium channel intermediate-conductance Ca-activated blocker
0,179  0,081  Hepatoprotectant
0,131  0,033  Breast cancer-resistant protein inhibitor
0,109  0,012  Peroxisome proliferator-activated receptor gamma antagonist
0,102  0,005  Anesthetic inhalation
0,174  0,077  Mutagenic
0,121  0,024  Restless leg syndrome treatment
0,118  0,022  Keratolytic
0,133  0,037  Antineoplastic, alkylator
0,217  0,122  Antiepileptic
0,144  0,050  Alkylator
0,136  0,042  Constipation treatment
0,104  0,010  Thromboxane antagonist
0,127  0,033  Anabolic
0,184  0,091  Antiviral (Ebola)
0,106  0,013  Protease 3C (Human rhinovirus) inhibitor
0,110  0,018  Leukotriene antagonist
0,106  0,014  NMDA receptor glycine site agonist
0,119  0,027  Ornithine decarboxylase inhibitor
0,137  0,046  Contraceptive female
0,100  0,009  Oleamide hydrolase inhibitor
0,151  0,060  Pancreatic disorders treatment
0,101  0,010  Glutamate (mGluR6) antagonist
0,115  0,025  Bile acid receptor antagonist
0,115  0,026  Tocolytic
0,131  0,042  HDL-cholesterol increasing
0,098  0,009  Potassium channel Kv1.3 blocker
0,187  0,099  Antialcoholic
0,125  0,037  Creatine kinase inhibitor
0,150  0,063  CNS active muscle relaxant
0,155  0,068  Antidote
0,158  0,071  Diuretic
0,096  0,009  Thromboxane A2 antagonist
0,091  0,004  Melatonin receptor 1A agonist
0,147  0,061  Calcium channel blocker
0,104  0,018  Prostaglandin EP2 antagonist
0,140  0,055  DNA polymerase I inhibitor
0,095  0,012  Exportin-1 inhibitor
0,088  0,006  Liver X receptor alpha agonist
0,141  0,059  Antiseptic
0,128  0,045  NAT2 substrate
0,088  0,006  Prostaglandin agonist
0,115  0,032  Antiviral (Rhinovirus)
0,142  0,060  Skin whitener
0,098  0,016  Carbonic anhydrase VB inhibitor
0,116  0,036  Tourette's syndrome treatment
0,124  0,044  Multidrug resistance-associated protein 1 inhibitor
0,107  0,027  Glutamate dehydrogenase inhibitor
0,122  0,042  Mental retardation treatment
0,153  0,073  Aldose reductase substrate
0,120  0,041  Sphingomyelinase inhibitor
0,087  0,008  DNA helicase inhibitor
0,134  0,055  Growth stimulant
0,132  0,054  Protein-tyrosine phosphatase 1B inhibitor
0,143  0,065  Bone formation stimulant
0,084  0,007  Ryanodine receptor antagonist
0,082  0,005  Cytokine production stimulant
0,082  0,005  Immunoglobulin Fc receptor antagonist
0,206  0,129  Antidiabetic (type 2)
0,090  0,014  Peroxisome proliferator-activated receptor alpha agonist
0,117  0,043  Potassium channel (Ca-activated) activator
0,096  0,022  Carbamoyl phosphate synthetase inhibitor
0,099  0,025  T cell inhibitor
0,092  0,019  Aldose reductase inhibitor
0,123  0,051  Aldehyde dehydrogenase substrate
0,094  0,021  GABA B receptor agonist
0,093  0,022  Anticholelithogenic
0,110  0,038  Phosphodiesterase IV inhibitor
0,117  0,045  Dementia treatment
0,078  0,006  Peroxisome proliferator-activated receptor delta antagonist
0,092  0,021  Dopamine uptake inhibitor
0,104  0,033  Chymotrypsin inhibitor
0,132  0,062  M18 aspartyl aminopeptidase inhibitor
0,090  0,020  Purinergic P2X1 antagonist
0,085  0,015  MDM2 inhibitor
0,079  0,010  Lysophosphatidic acid 3 receptor antagonist
0,090  0,020  TRPA1 antagonist
0,104  0,035  NAD(P)H dehydrogenase (quinone) inhibitor
0,083  0,014  Leukotriene B4 antagonist
0,120  0,051  Myasthenia Gravis treatment
0,153  0,085  Growth hormone agonist
0,169  0,101  Pyruvate kinase inhibitor
0,128  0,060  Antiprotozoal (Amoeba)
0,100  0,032  Glycine receptor antagonist
0,113  0,045  Vascular dementia treatment
0,142  0,077  Corneal wound healing stimulator
0,075  0,010  Adenylate cyclase 1 inhibitor
0,102  0,037  ATPase (Vacuolar H+) inhibitor
0,126  0,060  Antineoplastic antimetabolite
0,108  0,042  Interleukin 12 antagonist
0,142  0,077  Neuropeptide Y1 antagonist
0,116  0,051  Antiprotozoal (Toxoplasma)
0,075  0,010  Pregnane X receptor antagonist
0,087  0,023  Argininosuccinate synthase inhibitor
0,139  0,075  Pregnane X receptor agonist
0,075  0,011  Adenosine deaminase inhibitor
0,081  0,016  Carbonic anhydrase XIV inhibitor
0,077  0,013  Leukocyte elastase inhibitor
0,092  0,029  Calcium channel L-type blocker
0,263  0,201  Apoptosis agonist
0,116  0,053  Antiviral (Poxvirus)
0,071  0,010  Retinoid X receptor agonist
0,066  0,005  Liver X receptor beta antagonist
0,125  0,063  DNA repair enzyme inhibitor
0,071  0,010  Cholesterol esterase inhibitor
0,086  0,025  Endocannabinoid uptake inhibitor
0,119  0,058  GABA receptor agonist
0,103  0,043  Histamine N-methyltransferase inhibitor
0,081  0,021  Antiviral (Parainfluenza)
0,064  0,005  Kynurenine 3 monooxygenase inhibitor
0,104  0,045  Antifungal (Candida)
0,083  0,025  Beta adrenoreceptor antagonist
0,081  0,022  Acyl-CoA dehydrogenase inhibitor
0,071  0,012  Glucose-6-phosphate isomerase inhibitor
0,103  0,045  Paget's disease treatment
0,160  0,102  UDP-glucuronosyltransferase substrate
0,070  0,012  Heparanase inhibitor
0,110  0,052  Chronic obstructive bronchitis treatment
0,066  0,009  Benzodiazepine antagonist
0,076  0,019  Calcium channel P-type blocker
0,147  0,090  Cystic fibrosis treatment
0,080  0,023  Antimycoplasmal
0,061  0,005  Methionyl aminopeptidase 1 inhibitor
0,083  0,027  Potassium channel (Tandem pore domain) blocker
0,070  0,014  Leukotriene C antagonist
0,128  0,072  Antihemorrhagic
0,063  0,008  Liver X receptor beta agonist
0,241  0,186  Antibacterial
0,076  0,021  Beta 1 adrenoreceptor antagonist
0,090  0,035  NAT1 substrate
0,067  0,013  Carnitine palmitoyltransferase 1B inhibitor
0,079  0,026  Antidote, heavy metal
0,070  0,017  Thromboxane synthase inhibitor
0,062  0,010  Guanylate cyclase inhibitor
0,097  0,045  Bromodomain-containing protein 2 inhibitor
0,077  0,025  Nitric oxide donor
0,056  0,005  Prostaglandin EP4 agonist
0,055  0,004  Prostaglandin F2 alpha agonist
0,140  0,089  Anticoagulant
0,152  0,102  Lipocortins synthesis antagonist
0,055  0,005  Liver X receptor alpha antagonist
0,069  0,019  Epithelial sodium channel blocker
0,061  0,011  Dopamine D5 agonist
0,060  0,010  Peroxisome proliferator-activated receptor delta agonist
0,098  0,048  NMDA receptor antagonist
0,054  0,004  Elastase 2B inhibitor
0,054  0,004  Elastase 3A inhibitor
0,054  0,004  Elastase 3B inhibitor
0,090  0,040  Na+ K+ transporting ATPase inhibitor
0,054  0,005  Tryptophan 5 hydroxylase inhibitor
0,221  0,172  Beta lactamase inhibitor
0,090  0,041  CYP2A6 inhibitor
0,057  0,008  Angiotensin AT1 receptor antagonist
0,062  0,013  Dopamine beta hydroxylase inhibitor
0,178  0,130  Myocardial infarction treatment
0,059  0,011  Retinoid X alpha receptor agonist
0,056  0,008  Glutamate (mGluR8) agonist
0,056  0,008  Retinoid X receptor antagonist
0,056  0,009  Kainate receptor agonist
0,077  0,029  Uterine relaxant
0,066  0,020  Alpha-mannosidase inhibitor
0,055  0,009  Liver X receptor antagonist
0,113  0,067  Calcium channel (voltage-sensitive) blocker
0,067  0,021  Bombesin 2 receptor antagonist
0,088  0,042  CC chemokine 5 receptor agonist
0,165  0,120  Histone acetyltransferase inhibitor
0,087  0,043  Phosphodiesterase 4D inhibitor
0,089  0,046  D-Ala-D-Ala ligase inhibitor
0,080  0,037  S-adenosyl-L-methionine decarboxylase inhibitor
0,048  0,004  Lysophosphatidic acid receptor 1 agonist
0,147  0,104  Amyloid beta precursor protein antagonist
0,080  0,037  Amidase inhibitor
0,187  0,145  Neuropeptide Y2 antagonist
0,062  0,020  Antiviral (Herpesvirus 3, Human)
0,059  0,017  Liver X receptor agonist
0,078  0,036  Acetylcholine M5 receptor agonist
0,052  0,011  Glutamate (mGluR3) antagonist
0,045  0,004  Nicotinic acid receptor 2 antagonist
0,061  0,020  CD45 antagonist
0,048  0,007  Retinoid X alpha receptor antagonist
0,063  0,023  Nicotinic alpha3beta2 receptor antagonist
0,049  0,008  Peroxisome proliferator-activated receptor alpha antagonist
0,089  0,049  GABA A receptor agonist
0,136  0,096  Sigma receptor agonist
0,044  0,004  Thyroid hormone alpha antagonist
0,130  0,091  Skeletal muscle relaxant
0,132  0,093  Hemostatic
0,045  0,006  Prostaglandin E2 agonist
0,048  0,010  Vanilloid 3 antagonist
0,070  0,032  Carbonic anhydrase stimulant
0,138  0,100  Movement disorders treatment
0,046  0,009  Angiotensin II receptor antagonist
0,050  0,013  Vesicle monoamine transporter inhibitor
0,055  0,018  Geranyltranstransferase inhibitor
0,121  0,085  Alkaline phosphatase inhibitor
0,041  0,006  Thyroid hormone agonist
0,059  0,024  Vanilloid 2 antagonist
0,050  0,015  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,066  0,031  Calcium channel T-type blocker
0,046  0,011  Free fatty acid receptor 1 antagonist
0,053  0,019  NMDA receptor subunit 3A antagonist
0,063  0,029  Postcoital contraceptive
0,059  0,025  Prolyl endopeptidase inhibitor
0,051  0,017  Plasmepsin II inhibitor
0,049  0,015  Nicotinic acid receptor agonist
0,154  0,120  Angiogenesis stimulant
0,040  0,006  Elastase 2 inhibitor
0,040  0,006  Elastase 2A inhibitor
0,052  0,018  GABA B receptor antagonist
0,049  0,015  Heme oxygenase inhibitor
0,054  0,021  Mannosidase inhibitor
0,046  0,014  Leukotriene C4 antagonist
0,196  0,163  AR expression inhibitor
0,036  0,004  Carbonic anhydrase X inhibitor
0,036  0,004  Carbonic anhydrase VIII inhibitor
0,058  0,026  Beta 2 adrenoreceptor antagonist
0,050  0,018  Urate transporter 1 inhibitor
0,063  0,031  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,039  0,008  Calcium-sensing receptor agonist
0,035  0,004  Vesicular glutamate transport inhibitor
0,069  0,038  Antiemphysemic
0,049  0,018  Dihydropteroate synthase inhibitor
0,050  0,019  Dihydrofolate reductase inhibitor
0,087  0,056  Antileprosy
0,048  0,017  TRPM8 blocker
0,058  0,027  Diacylglycerol O-acyltransferase inhibitor
0,051  0,021  AICAR transformylase inhibitor
0,104  0,074  Electron transport complex I inhibitor
0,081  0,052  Cell adhesion molecule inhibitor
0,043  0,013  Carnitine palmitoyltransferase inhibitor
0,047  0,018  GABA uptake inhibitor
0,106  0,077  Antitussive
0,066  0,037  NMDA 2C receptor antagonist
0,042  0,014  Carnitine palmitoyltransferase 1 inhibitor
0,081  0,053  Arylamine N-Acetyltransferase substrate
0,075  0,047  Epoxide hydrolase inhibitor
0,106  0,079  Adenylate cyclase inhibitor
0,070  0,043  Selectin antagonist
0,049  0,022  Glutamate (mGluR group III) antagonist
0,054  0,027  Squalene epoxidase inhibitor
0,033  0,007  Acid ceramidase inhibitor
0,046  0,020  Membrane dipeptidase inhibitor
0,137  0,111  Dual specificity phosphatase inhibitor
0,125  0,100  Antiviral (Influenza A)
0,083  0,057  Inducible nitric-oxide synthase inhibitor
0,050  0,025  Sphingosine 1-phosphate receptor agonist
0,063  0,038  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,049  0,026  Fructose-1,6-bisphosphatase inhibitor
0,041  0,017  Prostacyclin antagonist
0,060  0,037  VEGFR2 expression inhibitor
0,037  0,014  Epoxide hydrolase 1 inhibitor
0,033  0,010  Prostaglandin H2 antagonist
0,037  0,015  Calcium-independent phospholipase A2 inhibitor
0,032  0,009  Glucosylceramidase stimulant
0,095  0,074  Folate antagonist
0,088  0,066  Thioredoxin inhibitor
0,034  0,013  Prostaglandin EP4 antagonist
0,032  0,011  NMDA receptor glycine site antagonist
0,158  0,137  Antiamyloidogenic
0,057  0,036  Maillard reaction inhibitor
0,035  0,015  Leukotriene B4 receptor 1 antagonist
0,027  0,006  Neuraminidase (Influenza B) inhibitor
0,054  0,034  NMDA 2A receptor antagonist
0,065  0,045  Neutrophil collagenase inhibitor
0,093  0,073  Nitric-oxide synthase inhibitor
0,049  0,030  Aldosterone antagonist
0,075  0,056  Nicotinic alpha4beta2 receptor antagonist
0,225  0,205  Transcription factor inhibitor
0,099  0,079  Antifungal (Aspergillus)
0,063  0,044  5 Hydroxytryptamine 2A agonist
0,121  0,102  Farnesoid X receptor antagonist
0,144  0,125  Antiviral (Hepatitis)
0,035  0,016  Glutamate (mGluR3) agonist
0,037  0,018  Benzodiazepine receptor peripheral-type antagonist
0,066  0,048  Antihemophilic
0,045  0,027  Glutamate (mGluR4) antagonist
0,111  0,092  Retinoprotector
0,076  0,057  Metalloproteinase-2 inhibitor
0,134  0,116  Antiviral (Hepatitis C)
0,064  0,045  CDC25B inhibitor
0,080  0,062  Sleep apnea treatment
0,078  0,060  Adrenaline agonist
0,023  0,005  Complement factor D inhibitor
0,040  0,023  Diamine oxidase inhibitor
0,081  0,063  Antiviral (Trachoma)
0,022  0,005  Lysophosphatidic acid receptor 3 agonist
0,118  0,100  Nav1.6 sodium channel blocker
0,061  0,044  Trypsin inhibitor
0,128  0,111  Muscle relaxant
0,023  0,007  Estrogen-related receptor gamma agonist
0,030  0,013  Hedgehog signaling activator
0,034  0,017  Lysophosphatidic acid 2 receptor antagonist
0,053  0,037  Ornithine carbamoyltransferase inhibitor
0,089  0,073  Xanthine oxidase inhibitor
0,021  0,005  Thromboxane A2 agonist
0,021  0,005  Angiotensin AT1B receptor antagonist
0,138  0,123  Hearing loss treatment
0,028  0,013  Prostaglandin EP2 agonist
0,096  0,081  5 Hydroxytryptamine 3A agonist
0,037  0,022  Phosphoglycerate kinase inhibitor
0,025  0,011  Isoleucine-tRNA ligase inhibitor
0,046  0,032  Carbonic anhydrase VII inhibitor
0,128  0,114  Pulmonary hypertension treatment
0,025  0,011  ICAM 1 antagonist
0,034  0,020  GABA transporter 3 inhibitor
0,222  0,209  DNA polymerase beta inhibitor
0,091  0,078  Urease inhibitor
0,024  0,011  Lysophosphatidic acid 1 receptor antagonist
0,070  0,058  Adenosine A3 receptor antagonist
0,219  0,206  Alpha-glucosidase inhibitor
0,032  0,019  Prostaglandin D2 agonist
0,068  0,056  Lipase inhibitor
0,053  0,041  Dihydroorotate oxidase inhibitor
0,062  0,050  Beta 3 adrenoreceptor antagonist
0,064  0,052  Potassium channel (ATP-sensitive) blocker
0,017  0,005  Carbonic anhydrase XI inhibitor
0,021  0,009  Antibiotic Anthracycline-like
0,040  0,029  Toll-Like receptor 2 agonist
0,032  0,021  Cholesterol ester transfer protein antagonist
0,063  0,052  Phosphodiesterase 4B inhibitor
0,038  0,026  Farnesoid X receptor agonist
0,078  0,067  Antineoplastic alkaloid
0,024  0,013  Glutamate (mGluR1a) agonist
0,024  0,013  GRP78 expression inhibitor
0,104  0,093  Retinopathy treatment
0,092  0,082  AMP-activated protein kinase stimulant
0,052  0,042  Matrix metalloproteinase (membrane-type) inhibitor
0,181  0,171  CYP2D6 inhibitor
0,018  0,009  Thyroid hormone alpha agonist
0,052  0,043  Sphingosine 1-phosphate receptor 5 agonist
0,071  0,062  Vanilloid 4 agonist
0,028  0,019  Uridine phosphorylase inhibitor
0,017  0,009  Microsomal triglyceride transfer protein inhibitor
0,031  0,023  ATP citrate lysase inhibitor
0,051  0,043  GABA receptor antagonist
0,028  0,019  LFA antagonist
0,042  0,034  Dihydroorotase inhibitor
0,055  0,047  Botulinum neurotoxin type A inhibitor
0,099  0,091  Beta amyloid protein antagonist
0,083  0,075  Alcohol dehydrogenase inhibitor
0,067  0,060  Phospholipase D inhibitor
0,021  0,014  Retinoid X beta receptor antagonist
0,035  0,028  5-Alpha-reductase inhibitor
0,033  0,026  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,044  0,037  Beta adrenoreceptor agonist
0,049  0,042  GABA A receptor antagonist
0,021  0,014  Integrin alpha4beta7 antagonist
0,045  0,038  Dopamine transporter inhibitor
0,031  0,024  Sirtuin 2 inhibitor
0,035  0,029  Integrin alpha2 antagonist
0,041  0,034  Nerve growth factor antagonist
0,066  0,060  Antibiotic
0,054  0,048  Sphingosine 1-phosphate receptor 3 antagonist
0,052  0,046  Aminopeptidase microsomal inhibitor
0,085  0,079  Protease inhibitor
0,034  0,028  Arginase inhibitor
0,030  0,024  Squalene synthetase inhibitor
0,127  0,122  Muscular dystrophy treatment
0,066  0,060  Bulimia treatment
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,039  0,035  Histamine H2 receptor agonist
0,032  0,028  HMG CoA reductase inhibitor
0,020  0,017  Excitatory amino acid transporter 3 inhibitor
0,060  0,056  Transcription factor RelA inhibitor
0,103  0,099  Antiacne
0,039  0,035  Sphingosine 1-phosphate receptor 1 agonist
0,016  0,013  G-protein-coupled receptor 120 agonist
0,039  0,035  Cholesterol absorption inhibitor
0,011  0,007  Thromboxane agonist
0,013  0,010  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,169  0,166  Cardioprotectant
0,039  0,036  NMDA receptor subunit 3B antagonist
0,117  0,114  Acetylcholine M1 receptor antagonist
0,052  0,049  Sphingosine 1-phosphate receptor 1 antagonist
0,066  0,064  Metalloproteinase-9 inhibitor
0,036  0,033  Kainate receptor antagonist
0,025  0,022  Integrin alpha2beta1 antagonist
0,011  0,008  Calcineurin inhibitor
0,129  0,126  Amyloid beta aggregation inhibitor
0,108  0,106  Lipid peroxidase inhibitor
0,024  0,023  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,009  0,007  Folate transporter 1 inhibitor
0,015  0,014  Vitamin D receptor agonist
0,043  0,042  Metalloproteinase-3 inhibitor
0,040  0,039  Histamine H1 receptor agonist
0,216  0,215  DNA directed DNA polymerase inhibitor
0,024  0,023  Complement factor 1s inhibitor
0,017  0,015  CXC chemokine 5 receptor antagonist
0,011  0,010  Integrin beta2 antagonist
0,058  0,057  Matrix metalloproteinase inhibitor
0,061  0,061  Gaucher disease treatment
0,053  0,053  Cathepsin E inhibitor
0,019  0,018  Retinoid X beta receptor agonist
0,084  0,084  Antiviral (Hepatitis A)

